Neurobiology of addiction

Current Opinion in Neurobiology

Volumn 6, Issue 2, 1996, Pages 243-251

  Wise, Roy A ^a  

^a Gina Cody School of Engineering and Computer Science   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; DIAMORPHINE; NICOTINE; PHENCYCLIDINE;

ADDICTION; BRAIN REGION; DRUG ABUSE; DRUG DEPENDENCE; DRUG MECHANISM; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; NEUROBIOLOGY; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; REWARD;

EID: 0029888444     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-4388(96)80079-1     Document Type: Article

References (96)

1. Wise RA, Rompré P-P: Brain dopamine and reward. Annu Rev Psychol 1989, 40:191-225.
2. Wise RA: The role of reward pathways in the development of drug dependence. Pharmacol Ther 1987, 35:227-263.
3. Wise RA, Bozarth MA: A psychomotor stimulant theory of addiction. Psychol Rev 1987, 94:469-492.
4. Wise RA: The neurobiology of craving: implications for understanding and treatment of addiction. J Abnorm Psychol 1988, 97:118-132.
5. Di Chiara G, Imperato A: Drugs of abuse preferentially stimulate dopamine release in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988, 85:5274-5278.
6. Koob GF, Bloom FE: Cellular and molecular mechanisms of drug dependence. Science 1988, 242:715-723.
7. Robinson TE, Berridge KC: The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 1993, 18:247-292.
8. Olds J, Milner PM: Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol 1954, 47:419-427.
9. Olds J: Pleasure centers in the brain. Sci Am 1956, 195:105-116.
10. Pickens R, Harris WC: Self-administration of D-amphetamine by rats. Psychopharmacologia 1968, 12:158-163.
11. Bozarth MA, Wise RA: Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science 1984, 224:516-518.
12. Dackis CA, Gold MS: New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev 1985, 9:469-477.
13. Markou A, Koob GF: Postcocaine anhedonia: an animal model of cocaine withdrawal. Neuropsychopharmacology 1991, 4:17-26.
14. Carlezon WA Jr, Wise RA: Rewarding actions of phencyclidine and related drugs in nucleus accumbens shell and frontal cortex. J Neurosci 1996, in press.
15. Devane WA, Axelrod J: Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes. Proc Natl Acad Sci USA 1994, 91:6698-6701. This paper and others [16-18] document the identification of cannabinoid receptors and their endogenous ligands. These findings should mark the beginning of a period of rapid progress with what has, until now, proven a difficult problem: the identification of the sites and mechanisms of action of the habit-forming cannabinoids.
16. Di Marzo V, Fontana A, Cadas H, Schinell S, Cimino G, Schwartz JC, Piomelli O: Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 1994, 372:686-691.
17. Evans DM, Lake JT, Johnson MR, Howlett AC: Endogenous cannabinoid receptor binding activity released from rat brain slices by depolarization. J Pharmacol Exp Ther 1994, 268:1271-1277.
18. Vogel Z, Barg J, Levy R, Saya D, Heldman E, Mechoulam R: Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J Neurochem 1993, 61:352-355.
19. Bozarth MA, Wise RA: Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci 1981, 28:551-555.
20. Phillips AG, LePiane FG: Reinforcing effects of morphine microinjection into the ventral tegmental area. Pharmacol Biochem Behav 1980, 12:965-968.
21. Devine DP, Wise RA: Self-administration of morphine, DAMGO, and DPDPE into the ventral tegmental area of rats. J Neurosci 1994, 14:1978-1984. This paper on intracranial self-administration and the complementary paper on conditioned place-preference [22] provide converging evidence for the same conclusion: mu and delta opioid actions in the ventral tegmental area are habit-forming, with mu actions being the more effective. This study also shows that the relative effectiveness of the mu and delta agonists in this paradigm are the same as their relative efficacies in elevating nucleus accumbens dopamine in acute microdialysis studies [25].
22. Bals-Kubik R, Ableitner A, Herz A, Shippenberg TS: Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J Pharmacol Exp Ther 1993, 264:489-495.
23. Johnson SW, North RA: Opioids excite dopamine neurons by hyperpolarization of local interneurons. J Neurosci 1992, 12:483-488.
24. Leone P, Pocock D, Wise RA: Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release. Pharmacol Biochem Behav 1991, 39:469-472.
25. Devine DP, Leone P, Pocock D, Wise RA: Differential involvement of ventral tegmental mu, delta, and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies. J Pharmacol Exp Ther 1993, 266:1236-1246.
26. Devine DP, Leone P, Carlezon WA Jr, Wise RA: Ventral mesencephalic δ opioid receptors are involved in modulation of basal mesolimbic dopamine neurotransmission. Brain Res 1993, 622:348-352.
27. Mucha RF, Herz A: Motivational properties of κ and μ opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology 1985, 86:274-280.
28. Wise RA, Leone P, Rivest R, Leeb K: Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self-administration. Synapse 1995, 21:140-148.
29. Kiyatkin EA, Wise RA, Gratton A: Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous heroin self-administration in rats. Synapse 1993, 14:60-72.
30. Hemby SE, Martin TJ, Co C, Dworkin SI, Smith JE: The effects of intravenous heroin administration on extracellular nucleus accumbens dopamine concentrations as determined by in vivo microdialysis. J Pharmacol Exper Ther 1995, 273:591-598. This study suggests that the effects of heroin on the dopamine system decrease, indeed disappear, with progressive self-administration experience. This finding is inconsistent with other reports [28,29] suggesting that this issue needs further investigation.
31. Clarke PBS, Pert A: Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res 1985, 348:355-358.
32. Imperato A, Mulas A, Di Chiara G: Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol 1986, 132:337-338.
33. Mereu G, Yoon K-WP, Boi V, Gessa GL, Naes L, Westfall TC: Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. Eur J Pharmacol 1987, 141:395-400.
34. Museo E, Wise RA: Place preference conditioning with ventral tegmental injections of cytisine. Life Sci 1994, 55:1179-1186.
35. Corrigall WA, Coen KM: Selective dopamine antagonists reduce nicotine self-administration. Psychopharmacology 1991, 104:171-176.
36. Corrigall WA, Franklin KBJ, Coen KM, Clarke P: The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology 1992, 107:285-289.
37. Corrigall WA, Coen KM, Adamson KL: Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 1994, 653:278-284.
38. Pettit HO, Justice JB: Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis. Pharmacol Biochem Behav 1989, 34:899-904.
39. Hurd JL, Weiss F, Koob GF, Anden N-E, Ungerstedt U: Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens: an in vivo microdialysis study. Brain Res 1989, 498:199-203.
40. •] data are in disagreement as to whether dopamine levels increase in anticipation or receipt of cocaine reinforcement.
41. Kiyatkin EA, Stein EA: Biphasic changes in mesolimbic dopamine signal during cocaine self-administration. Neuroreport 1994, 5:1005-1008.
42. Gratton A, Wise RA: Drug- and behavior-associated changes in dopamine-related electrochemical signals during intravenous cocaine self-administration in rats. J Neurosci 1994, 14:4130-4146.
43. •,41,42].
44. Carelli RM, Deadwyler SA: A comparison of nucleus accumbens neuronal firing patterns during cocaine self-administration and water reinforcement in rats. J Neurosci 1994, 14:7735-7746. This paper and others [45,46] represent the initial attempts to monitor cellular responses in the mesolimbic system during drug self-administration. Of greater immediate interest would be responses of the dopamine-containing cells of the ventral tegmental area, but these cells are difficult to record and have not yet been recorded successfully in animals responding for drug reward. Such cells have been successfully recorded during food reward (see [47]).
45. Carelli RM, King VC, Hampson RE, Deadwyler SA: Firing patterns of nucleus accumbens neurons during cocaine self-administration in rats. Brain Res 1993, 626:14-22.
46. Chang JY, Sawyer SF, Lee RS, Woodward DJ: Electrophysiological and pharmacological evidence for the role of the nucleus accumbens in cocaine self-administration in freely moving rats. J Neurosci 1994, 14:1224-1244.
47. Schultz W, Apicella P, Ljungberg T: Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task. J Neurosci 1993, 13:900-913.
48. Hoebel BG, Monaco AP, Hernandez L, Aulisi EF, Stanley BG, Lenard L: Self-injection of amphetamine directly into the brain. Psychopharmacology 1983, 81:158-163.
49. Phillips GD, Robbins TW, Everitt BJ: Bilateral intra-accumbens self-administration of D-amphetamine: antagonism with intra-accumbens SCH-23390 and sulpiride. Psychopharmacology 1994, 114:477-485. An important confirmation and extension of earlier work in another laboratory [48]. Demonstrations of intracranial drug self-administration are problematic, and this is a paradigm where it is important that critical findings be confirmed and extended by independent groups.
50. Carlezon WA Jr, Devine DP, Wise RA: Habit-forming actions of nomifensine in nucleus accumbens. Psychopharmacology 1995, 122:194-197. Although the bulk of the evidence suggests that the habit-forming actions of cocaine are localized to the nucleus accumbens, cocaine is readily self-administered by rats into frontal cortex and not nucleus accumbens [52]. This problematic cocaine finding is confirmed herein, but, in addition, this paper reports that nomifensine, a drug that shares cocaine's dopamine uptake inhibiting action, is readily self-administered into the nucleus accumbens. This finding suggests a partial resolution of the cocaine data [52] that have been problematic for several years.
51. Pickel VM, Chan J: Spiny neurons lacking choline acetylcholine transferase immunoreactivity are major targets of cholinergic and catecholaminergic terminals in rat striatum. J Neurosci Res 1990, 25:263-280.
52. Goeders NE, Smith JE: Cortical dopaminergic involvement in cocaine reinforcement Science 1983, 221:773-775.
53. Hurd YL, Ungerstedt U: Cocaine: an in vivo microdialysis evaluation of its acute action on dopamine transmission in rat striatum. Synapse 1989, 3:48-54.
54. Dworkin SI, Goeders NE, Smith JE: The reinforcing and rate effects of intracranial dopamine administration. NIDA Res Monogr 1986, 67:242-248.
55. Olds ME: Reinforcing effects of morphine in the nucleus accumbens. Brain Res 1982, 237:429-440.
56. Goeders NE, Lane JD, Smith JE: Self-administration of methionine enkephalin into the nucleus accumbens. Pharmacol Biochem Behav 1984, 20:451-455.
57. o proteins in nucleus accumbens reduces both cocaine and heroin reinforcement. J Neurosci 1994, 14:6239-6247.
58. Terwilliger RZ, Beitner-Johnson D, Sevarino KA, Crain SM, Nestler EJ: A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res 1991, 548:100-110.
59. Sesack SR, Pickel VM: Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neurol 1992, 320:145-160.
60. Zahm DS, Brog JS: On the significance of subterritories in the 'accumbens' part of the rat ventral striatum. Neuroscience 1992, 50:751-767.
61. 2 dopamine receptors: visualization of cellular expression patterns in motor and limbic structures. Synapse 1995, 20:325-337.
62. Waters N, Svensson K, Haadsma-Svensson SR, Smith MW, Carlsson A: The dopamine D3-receptor: a postsynaptic receptor inhibitory on rat locomotor activity. J Neural Transm 1993, 94:11-19.
63. Goeders NE, Smith JE: Reinforcing properties of cocaine in the medial prefrontal cortex: primary action on presynaptic dopaminergic terminals. Pharmacol Biochem Behav 1986, 25:191-199.
64. Goeders NE, Dworkin SI, Smith JE: Neuropharmacological assessment of cocaine self-administration into the medial prefrontal cortex. Pharmacol Biochem Behav 1986, 24:1429-1440.
65. Martin-Iverson MT, Szostak C, Fibiger HC: 6-Hydroxydopamine lesions of the medial prefrontal cortex fail to influence intravenous self-administration of cocaine. Psychopharmacology 1986, 88:310-314.
66. Schenk S, Honger BA, Peltier R, Shelton K: Supersensitivity to the reinforcing effects of cocaine following 6-hydroxydopamine lesions to the medial prefrontal cortex in rats. Brain Res 1991, 543:227-235.
67. Goeders NE, Smith JE: Intracranial cocaine self-administration into the medial prefrontal cortex increases dopamine turnover in the nucleus accumbens. J Pharmacol Exp Ther 1993, 265:592-600.
68. Self DW, Stein L: Pertussis toxin attenuates intracranial morphine self-administration. Pharmacol Biochem Behav 1993, 46:689-695.
69. Stevens KE, Shiotsu G, Stein L: Hippocampal μ-receptors mediate opioid reinforcement in the CA3 region. Brain Res 1991, 545:8-16.
70. Sesack SR, Pickel VM: In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other. Brain Res 1990, 527:266-279.
71. Collier TJ, Routtenberg A: Electrical self-stimulation of dentate gyrus granule cells. Behav Neural Biol 1984, 42:85-90.
72. Yeomans JS, Mathur A, Tampakeras M: Rewarding brain stimulation: role of tegmental cholinergic neurons that activate dopamine neurons. Behav Neurosci 1993, 107:1077-1087.
73. Bechara A, Van der Kooy D: The tegmental pedunculopontine nucleus: a brain-stem output of the limbic system critical for the conditioned place preferences produced by morphine and amphetamine. J Neurosci 1989, 9:3400-3409.
74. Wise RA: Addictive drugs and brain stimulation reward. Annu Rev Neurosci 1996, 19:319-340. A review of studies that suggest that the interaction of addictive drugs with brain stimulation reward represents a synergism between the rewarding effects of the drug and the rewarding effects of the stimulation.
75. Leith NJ, Barrett RJ: Amphetamine and the reward system: evidence for tolerance and post-drug depression. Psychopharmacology 1976, 46:19-25.
76. Wise RA, Munn E: Withdrawal from chronic amphetamine elevates baseline intracranial self-stimulation thresholds. Psychopharmacology 1994, 117:130-136.
77. Frank RA, Martz S, Pommering T: The effect of chronic cocaine on self-stimulation train-duration thresholds. Pharmacol Biochem Behav 1988, 29:755-758.
78. Kokkinidis L, McCarter BD: Postcocaine depression and sensitization of brain-stimulation reward: analysis of reinforcement and performance effects. Physiol Behav 1990, 36:463-471.
79. Schulteis G, Markou A, Cole M, Koob GF: Decreased brain reward produced by ethanol withdrawal. Proc Natl Acad Sci USA 1995, 92:5880-5884.
80. Parsons LH, Smith AD, Justice JB: Basal extracellular dopamine is decreased in the rat nucleus accumbens during abstinence from chronic cocaine. Synapse 1991, 9:60-65.
81. Imperato A, Mele A, Scrocco MG, Puglisi-Allegra S: Chronic cocaine alters limbic extracellular dopamine. Neurochemical basis for addiction. Eur J Pharmacol 1992, 212:299-300.
82. Rossetti ZL, Hmaidan Y, Gessa GL: Marked inhibition of mesolimbic dopamine release: a common feature of ethanol, morphine, cocaine, and amphetamine abstinence in rats. Eur J Pharmacol 1992, 221:227-234.
83. Robertson MW, Leslie CA, Bennett JP Jr: Apparent synaptic dopamine deficiency induced by withdrawal from chronic cocaine treatment. Brain Res 1991, 538:337-339.
84. Paulson PE, Camp DM, Robinson TE: Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology 1991, 103:480-492.
85. Pothos E, Rada P, Mark GP, Hoebel BG: Chronic morphine increases synaptic dopamine in the nucleus accumbens and naloxone decreases it unless withdrawal is blocked with clonidine. Brain Res 1991, 566:348-350.
86. Self DW, Nestler EJ: Molecular mechanisms of drug reinforcement and addiction. Annu Rev Neurosci 1995, 18:463-495. An important review of the intracellular effects of addictive drugs within specified elements of brain reward circuitry.
87. Stewart J, Wise RA: Reinstatement of heroin self-administration habits: morphine prompts and naltrexone discourages renewed responding after extinction. Psychopharmacology 1992, 108:779-784.
88. Shaham Y, Stewart J: Stress reinstates heroin-seeking in drug-free animals: an effect mimicking heroin, not withdrawal. Psychopharmacology 1995, 119:334-341. Although drug-associated auditory or visual stimuli (tones or lights) have not proven particularly potent in provoking drug-seeking responses in laboratory animals with extinguished drug self-administration habits, this paper illustrates how stressful stimuli, never previously experienced, can do so. This paper opens a new and exciting line of research into the interaction of stress with addiction.
89. Stewart J, De Wit H, Eikelboom R: Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants. Psychol Rev 1984, 91:251-268.
90. Piazza PV, Deminiere JM, Le Moal M, Simon H: Factors that predict individual vulnerability to amphetamine self-administration. Science 1989, 245:1511-1513.
91. Horger BA, Shelton K, Schenk S: Preexposure sensitizes rats to the rewarding effects of cocaine. Pharmacol Biochem Behav 1990, 37:707-711.
92. ••] comprise a series of important papers on individual differences in the acquisition of intravenous drug self-administration habits.
93. Piazza PV, Marinelli M, Jodogne C, Deroche V, Rouge-Pont F, Maccari S, Le Moal M, Simon H: Inhibition of corticosterone synthesis by Metyrapone decreases cocaine-induced locomotion and relapse of cocaine self-administration. Brain Res 1994, 658:259-264. One of an important series of studies on the possible role of stress and stress history in individual differences in responsiveness to the habit-forming properties of addictive drugs.
94. Daunais JB, Roberts DCS, McGinty JF: Short-term cocaine self administration alters striatal gene expression. Brain Res Bull 1995, 37:523-527.
95. Nestler EJ, Hope BT, Widnell KL: Drug addiction: a model for the molecular basis of neural plasticity. Neuron 1993, 11:995-1006.
96. Van Bockstaele EJ, Pickel VM: GABA-containing neurons in the ventral tegmental area project to the nucleus accumbens in rat brain. Brain Res 1995, 682:215-221.